Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Pediatr Neurol. 2021 Oct 19;126:96–103. doi: 10.1016/j.pediatrneurol.2021.10.012

Table 1:

Demographic characteristics (including admission laboratory values) and outcomes, univariate pairwise analysis

Demographic
variable
Died
(n=28)
Survived with
neurologic
sequelae
(n=23)
Survived
without
neurologic
sequelae
(n=143)
P-value
comparing
those who
died vs.
survivors
P-value
survival with
vs. without
sequelae
Age (months): median (IQR) 36 (24.5 – 49.5) 36 (18 – 74) 55 (36 – 78) 0.0067* 0.04*
Blantyre coma score: count (%)
0 7 (25%) 5 (21.7%) 7 (4.9%) 0.001* <0.001*
1 15 (53.6%) 8 (34.8%) 62 (42.0%)
2 6 (21.4%) 10 (43.5%) 76 (53.1%)
Glucose (mg/dL): median (IQR) 86.4 (45.0 – 117.0) 104.4 (66.6 – 138.6) 104.4 (84.6 – 129.6) 0.015* 1.0
Platelets (x103)/ml: median (IQR) 48 (9.3 – 85.9) 43.4 (7.6 - 304) 1.7 (0.3 – 49.8) 0.089 0.084
Hematocrit (%):median (IQR) 26.1 (21 – 30.1) 20.5 (14.9 – 24) 23.4 (18.9 – 27) 0.057 0.048*
Time from onset of fever to hospital admission (hours): median (IQR) 48 (14 – 72) 48 (24 -72) 72 (48 – 72) 0.13 0.50
Time from onset of coma to hospital admission (hours): median (IQR) 10 (7 – 18) 24 (21 -48) 12 (7-24) 0.26 0.0006*
Time from last clinical convulsion until hospital admission (hours): median (IQR) 10 (5 – 24) 7 (0 – 24) 5 (0 - 15.5) 0.09 0.33
History of pre-hospital administration of benzodiazepines or barbiturates (%) 17 (60.7%) 12 (52.2%) 75 (53.2%) 0.45 0.93
Brain volume score
1-6 12 (44.4%) 20 (87%) 114 (80.3%) <0.001* 0.45
7-8 15 (55.6%) 3 (13%) 28 (19.7%)

Variables expressed as median (IQR) for continuous variables, counts (percent) for categorical variables. P-values using ANOVA or Wilcoxon -Mann-Whitney test for continuous variables, chi square for categorical; SD = standard deviation.